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Introduction {#sec1}
============

Parkinson\'s disease (PD) is a multifactorial neurodegenerative disorder characterized by motor and non-motor symptoms ([@bib3]). Some cases of PD cases result from autosomal dominant mutations in the *SNCA* gene, which encodes α-synuclein. Physiologically, α-synuclein is implicated in synaptic transmission and vesicle transport, while pathologically it is part of the protein aggregates known as Lewy bodies and Lewy neurites ([@bib8]). Patients carrying mutations in the *SNCA* gene suffer from early onset of PD. Mutations in *SNCA* include increase in gene dosage ([@bib5]) and heterozygous missense mutations such as p.A30P and p.A53T ([@bib1], [@bib25]). Mutations in *SNCA* can account for up to 15% of cases of familial early-onset PD ([@bib2]).

Importantly, genome editing tools can assist in parsing PD phenotypes. The reliability of CRISPR-Cas9 as an editing tool has been extensively validated by whole-genome sequencing ([@bib27]). Furthermore, Cas9 specificity has been improved with high-fidelity variants ([@bib13]). However, eliminating uncertainties in genotype outcomes of edited lines has remained challenging. Screening of correctly edited clones is a labor-consuming process that entails the selection of on-target knockin clones and the exclusion of random integrations, on-target indels, and second-allele indel events. To leverage the power of genome editing tools in the evaluation of polygenic diseases such as PD, it is necessary to overcome such labor- and time-consuming limitations. Hence, the fast generation of genome-edited populations carrying a known genotype outcome is highly necessary.

Results {#sec2}
=======

Deterministic Genotype Outcomes for the Generation of Isogenic Lines {#sec2.1}
--------------------------------------------------------------------

The use of donors containing fluorescent protein (FP) reporters associated with defined SNP variants enables editing outcomes of known genotype ([Figures 1](#fig1){ref-type="fig"}A and 1E): heterozygous, homozygous healthy, and homozygous pathogenic ([Figure 1](#fig1){ref-type="fig"}E). One-step biallelic targeting occurs with a mean frequency of 37.5% using double-stranded DNA (dsDNA) templates ([Table S1](#mmc1){ref-type="supplementary-material"}). Donor vectors for *SNCA* exon 2 and exon 3 were cloned with an internal positive selection module (PSM) coding EGFP or dTOMATO, and an external negative selection module (NSM) containing tagBFP ([Figure 1](#fig1){ref-type="fig"}A). *SNCA* mutations are dominant, and missense *SNCA* PD patients are heterozygote. Hence, donor pairs for the *SNCA* mutations rs104893878 (p.A30P) and rs104893877 (p.A53T) were designed to match heterozygous genotype outcomes ([Figure 1](#fig1){ref-type="fig"}E). In the case of *SNCA*e2, an EGFP donor carried the transversion c.88g\>c. For *SNCA*e3, an EGFP donor carried the transition c.209g\>a. For each locus, a corresponding dTOMATO donor carried the healthy variant, as shown for population type 1A ([Figure 1](#fig1){ref-type="fig"}E). A similar expression level of the FP reporters was observed from each allele in *SNCA* chromosome 4, as demonstrated by a symmetric fluorescence-activated cell sorting (FACS) analysis ([Figure 1](#fig1){ref-type="fig"}D). In order to test whether similar PSM expression levels are observed in other loci, the gene *PINK1* exon 5 of chromosome 1 was targeted. In contrast to *SNCA* mutant PD patients, *PINK1* PD patients are homozygote or compound heterozygote ([@bib11]). Hence, for *PINK1*e5, both donors, EGFP and dTOMATO, carried the pathogenic transversion c.1197t\>a, matching population type 1C ([Figure 1](#fig1){ref-type="fig"}E). FACS analysis showed that biallelic targeted populations separated clearly from other genotype outcomes for *PINK1* chromosome 1 ([Figure S1](#mmc1){ref-type="supplementary-material"}C) and *SNCA* chromosome 4 ([Figure 1](#fig1){ref-type="fig"}D). These results validate the approach to target both alleles of a gene of interest, independent of the locus.Figure 1Biallelic Integration of FP-SNP Pairs Enable Deterministic Genotype Outcomes(A) Donor vectors contain a PSM expressing EGFP or dTOMATO, and an NSM expressing tagBFP. PSMs contain puromycin resistance gene (Puro).(B) Representative example of *SNCA*e3 polyclone 636. Random integration tagBFP^pos^ cells are excluded from the correctly edited on-target cells tagBFP^neg^.(C) Theoretical distribution of populations for non-random outcomes.(D) Representative example of *SNCA*e3. On-target cells include homozygous populations, EGFP^pos^/EGFP^pos^ or dTOMATO^pos^/dTOMATO^pos^ (type 2), and heterozygous populations of undefined second-allele state EGFP^pos^/WT-NHEJ or dTOMATO^pos^/WT-NHEJ (type U). WT, wild-type.(E) Outcomes of the derived population are defined according to the donor vector design.(F) The tagBFP NSM allows removal of random integration events, assisting in the derivation of defined outcomes.

Repetitive Elements Reduce On-Target Genome Editing Efficiency by Increasing Random Integration {#sec2.2}
-----------------------------------------------------------------------------------------------

Silent point mutations were introduced in protospacer adjacent motif (PAM) sequences of the donors ([Table S2](#mmc1){ref-type="supplementary-material"}). The PAM edited template is resistant to Cas9-induced linearization, avoiding linear DNA-induced random integration. Thus, properly targeted alleles are shielded from Cas9-induced secondary incisions, eliminating the risk of on-target indels ([@bib18]) ([Table S2](#mmc1){ref-type="supplementary-material"}). Two weeks after electroporation, each edited population was expanded up to 15 × 10^6^ puromycin-resistant and FP-positive cells. The inclusion of tagBFP in the NSM allowed random integration events to be quantified, visualized, and excluded ([Figures 1](#fig1){ref-type="fig"}A, 1B, and 1F). The tagBFP NSM avoids bystander toxicity or incomplete negative selection from systems such as thymidine kinase ([@bib22]). The percentage of tagBFP^pos^ random integration ranged from 5.8% to 14.6% for *SNCA*e2, from 42.6% to 64.2% for *SNCA*e3, and from 27.2% to 30.4% for *PINK1*e5 ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C). The extent of random integration correlated with the type and proportion of repetitive elements present in the homology arms of the donors. We assessed random integration using donors for six loci with known repetitive element composition and tested 12 single-guide RNAs (sgRNAs). The loci evaluated included chromosome 1 (*PINK1* exon 5), chromosome 4 (*SNCA* exon 2 and exon 3), and chromosome 16 (ceroid lupofuscinosis 3, *CLN3* exon 5--8, exon 10--13, and exon 14--15) ([Figure S2](#mmc1){ref-type="supplementary-material"}G). For the analysis, we performed a linear optimization model of the form *Ax* = *b* ([Figure S2](#mmc1){ref-type="supplementary-material"}H). The resulting matrix *A* corresponds to the frequency of repetitive elements in the homology arms ([Figure S2](#mmc1){ref-type="supplementary-material"}G). The vector *x* corresponds to the type of repetitive elements present in the analyzed dataset ([Figure S2](#mmc1){ref-type="supplementary-material"}G) and a variable of all non-included repetitive elements (upsilon). The vector *b* corresponds to the experimentally measured random integration level, given by the percentage of tagBFP^pos^ cells ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2F). Based on this, we derived a model to predict random integration frequency intrinsic to the composition of repetitive elements in the homology arms ([Figures S2](#mmc1){ref-type="supplementary-material"}H and S2I). The solution allows assigning weight coefficients to each repetitive element. Their value indicates which repetitive element contributes the most to the random integration frequency observed. The solution space is constrained for a maximum of 100% random integration and sequence length boundaries of each repetitive element. The optimization solution indicates that the most relevant repetitive elements correspond to the Short Interspersed Nuclear Elements (SINE) family, specifically Alu and Mir ([Figures S2](#mmc1){ref-type="supplementary-material"}H and S2I).

FACS Purification Increases the Speed and Yield of Isogenic Derivation {#sec2.3}
----------------------------------------------------------------------

For the on-target tagBFP^neg^ cells, the ratio of EGFP to dTOMATO was ∼50% in all cases analyzed, which is consistent with a comparable efficiency for both donors ([Figures 2](#fig2){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}C). The initial percentage of double-positive EGFP^pos^/dTOMATO^pos^ cells ranged from a mean 2.15% for *SNCA*e2, 3.4% for *SNCA*e3, to 3.75% for *PINK1*e5 ([Figures 2](#fig2){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}C). Quantifications were conducted independently using different sgRNAs ([Figures 2](#fig2){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}C). One sorting step yielded a population of up to 3 × 10^5^ EGFP^pos^/dTOMATO^pos^ cells ([Figures 2](#fig2){ref-type="fig"}C and 2D). The gating position of the double-positive population afforded nearly complete purity with either purity-purity or yield-purity sorting masks ([Figures 2](#fig2){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}D). Although it is possible to isolate single-channel double-positive EGFP^pos/pos^ or dTOMATO^pos/pos^ populations (type 2) ([Figure 2](#fig2){ref-type="fig"}A) using the FSC-A dimension, there is an extensive overlap with the indel-bearing single-positive population (type U) ([Figures S1](#mmc1){ref-type="supplementary-material"}G--S1J). A high frequency of non-homologous end joining (NHEJ) events was detected in the non-targeted allele of the single-positive population (type U) ([Figures S1](#mmc1){ref-type="supplementary-material"}J and S1K). Hence, purification of the double-positive EGFP^pos/pos^ or dTOMATO^pos/pos^ populations presents the risk of co-purifying overlapping indel-bearing cells ([Figures S1](#mmc1){ref-type="supplementary-material"}J and S1K). In this combination of events, only the biallelic EGFP^pos^/dTOMATO^pos^ group offers a deterministic genotype outcome. Sanger sequencing of biallelic targeted *SNCA* mutations demonstrated the heterozygous integration of the pathogenic SNP rs104893878 (p.A30P) and rs104893877 (p.A53T) in each polyclone ([Figures 2](#fig2){ref-type="fig"}E and 2F), the homozygous integration of the edited PAM, and the transition from genome to PSM ([Figures 2](#fig2){ref-type="fig"}E and 2F). Sequencing-isolated single clones from the polyclonal populations permitted composition analysis ([Figures 2](#fig2){ref-type="fig"}G, [S3](#mmc1){ref-type="supplementary-material"}F, and S3G and [Table S3](#mmc1){ref-type="supplementary-material"}).Figure 2FACS Purification Increases the Speed and Yield of Isogenic Derivation(A) Post-selection sorting of double-positive biallelic edited cells for *SNCA*e2 and *SNCA*e3 using independent sgRNAs. FACS plots are represented with 2% contour lines. For *SNCA*e3 sgRNA-636, a dotplot is included to show the distribution of 1.2%. Diagram of knockin population types is shown (right).(B) Yield-purity and purity-purity sorting strategies permit the generation of a homogeneous biallelic knockin population. Diagram of purification population types is shown (right).(C) Representative post-sorting of single cells for *SNCA* polyclone. Single-cell gating structures yields high-purity biallelic edited cells. Scale bar, 50 μm.(D) Representative post-sorting culture for biallelic EGFP^pos^/dTOMATO^pos^*SNCA* polyclone. Scale bar, 200 μm.(E) Sanger sequencing chromatogram of *SNCA*e2 p.A30P polyclone 632 knockin (KI).(F) Sanger sequencing chromatogram of *SNCA*e3 p.A53T polyclone 636 knockin.(G) Analysis of the polyclone composition as in [Figure S3](#mmc1){ref-type="supplementary-material"}.

Transposase-Mediated Generation of Footprint-free Isogenic Lines {#sec2.4}
----------------------------------------------------------------

The PSMs in each double-positive polyclone were excised using a codon-optimized hyperactive and excision-only variant of the piggybac transposase ([@bib16], [@bib28]) ([Figures 3](#fig3){ref-type="fig"}A and 3B). Even though the excision-only variant presents an activity of 0.85 times that of wild-type ([Figures S1](#mmc1){ref-type="supplementary-material"}M and S1N), it is preferred as it lacks the reintegration cycle of wild-type variants ([@bib15]). The heterozygous *SNCA*e2 and *SNCA*e3 EGFP^pos^/dTOMATO^pos^ polyclonal populations were transfected with *in vitro* transcribed mRNA encoding excision-only transposase. Subsequently, the excised EGFP^neg^/dTOMATO^neg^ population was sorted ([Figures 3](#fig3){ref-type="fig"}A and 3B). Using the excision-only variant and two transfection steps, we observed average excision efficiencies of 3.65% for *SNCA*e2, 2.15% for *SNCA*e3, and 6.5% for *PINK1*e5 ([Figures 3](#fig3){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}E). A second sorting step to purify cells that underwent selection module removal yielded up to 2.5 × 10^6^ EGFP^neg^/dTOMATO^neg^ SNP knocked in cells. In the FACS analysis, it is possible to observe transition states for single-copy excision and complete removal of both selection modules ([Figures 3](#fig3){ref-type="fig"}A, 3B, and [S1](#mmc1){ref-type="supplementary-material"}E). We observed a curved population shifting from the double-positive EGFP^pos^/dTOMATO^pos^ quadrant to the double-negative EGFP^neg^/dTOMATO^neg^ quadrant in all cases. Sanger sequencing of the *SNCA* targeted and transposed genomic region demonstrated the heterozygous integration of the pathogenic SNP rs104893878 (p.A30P) and rs104893877 (p.A53T) in each polyclone ([Figures 3](#fig3){ref-type="fig"}C and 3D). Isolation of single-cell-derived clones from the polyclones and sequencing permitted quantification of their composition ([Figures 3](#fig3){ref-type="fig"}E, [S3](#mmc1){ref-type="supplementary-material"}H, and S3I and [Table S3](#mmc1){ref-type="supplementary-material"}). The polyclone composition analysis demonstrated that PSMs were excised and the edited SNPs and edited PAM sites remained in the non-coding sequence ([Figures S3](#mmc1){ref-type="supplementary-material"}H and S3I). Karyotype assessment was conducted for each polyclone and parental control ([Figures S4](#mmc1){ref-type="supplementary-material"}A--S4C). Pluripotency of lines was assessed by immunostaining for OCT4, SOX2, TRA1-81, and SSEA4 ([Figures S4](#mmc1){ref-type="supplementary-material"}D--S4F).Figure 3Transposase-Mediated Excision of PSMs(A) FACS analysis for PSM removal. Two transfection steps of excision-only transposase result in removal of the PSMs for *SNCA*e2 and *SNCA*e3. Purification of EGFP^neg^/dTOMATO^neg^ cells yields footprint-free edited lines. Diagram of removal population types is shown (right).(B) Cultures after transposase transfection for *SNCA*e2 present single and double PSM removal events (in arrowheads) as shown in (A). Scale bar, 200 μm.(C) Sanger sequencing chromatogram of transposed *SNCA*e2 p.A30P polyclone 632 and parental control.(D) Sanger sequencing chromatogram of transposed *SNCA*e3 p.A53T polyclone 636 and parental control.(E) Analysis of the respective polyclone composition as in [Figure S3](#mmc1){ref-type="supplementary-material"}.

*SNCA* Mutants Present Early Mitochondrial Impairment {#sec2.5}
-----------------------------------------------------

In order to validate the edited *SNCA* lines, a phenotypic characterization was conducted ([Figure 4](#fig4){ref-type="fig"}). Isogenic induced pluripotent stem cells (iPSCs) were differentiated into neuroepithelial stem cells (NESCs) ([@bib21]) ([Figures 4](#fig4){ref-type="fig"}A, [S4](#mmc1){ref-type="supplementary-material"}G, and S4H). NESCs typically express the *SNCA* transcript at 0.86 and 0.7 times the level of *GAPDH* and *TUBG1*, respectively ([Figures 4](#fig4){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}I). Western blot analysis indicated a similar protein level of monomeric α-synuclein for all genotypes ([Figure 4](#fig4){ref-type="fig"}C). Extracellular energy flux analyses were conducted for parental healthy NESCs, and mutant isogenic α-synuclein p.A30P and p.A53T NESCs ([Figure 4](#fig4){ref-type="fig"}D). Cells expressing the α-synuclein mutation p.A53T showed a significantly reduced maximal respiration capacity compared with the parental isogenic control ([Figures 4](#fig4){ref-type="fig"}D--4F). Moreover, both the p.A30P and p.A53T α-synuclein mutant NESCs showed comparatively reduced energy performance, manifested by a lower basal respiration, ATP production, and non-mitochondrial respiration ([Figures 4](#fig4){ref-type="fig"}D--4F).Figure 4Edited *SNCA* Isogenic Lines Present PD-Associated Phenotypes(A) NESC differentiation protocol.(B) Microarray expression level for *SNCA*, *TUBG1*, and *GAPDH* in healthy control NESCs. Data represent three replicates.(C) Western blot subsequent to denaturing SDS-PAGE for α-synuclein and GAPDH for NESCs.(D) Wave plot of oxygen consumption rates for the α-synuclein isogenic set. Each wave corresponds to three biological replicates. SD of the sample is included.(E) Maximal respiration, proton leak, basal respiration, ATP production, and non-mitochondrial respiration for the extracellular energy flux analysis in (D).(F) Radar plot of fold changes for the parameters in (E). Significance levels correspond to the higher p value assigned to a mutant per category. Significance determined by unpaired Student\'s t-test.Significance levels are ^∗^p \< 0.05, ^∗∗^p \< 0.01 and ^∗∗∗^p \< 0.001; n.s., not significant.

Discussion {#sec3}
==========

Overall, FACE constitutes a robust method to achieve deterministic genotype outcomes for the generation of isogenic cell lines. The selection of biallelic editing events ensures a defined genotype. It should be noted that, due to transient disruption of the coding sequence, this approach is restricted to genes with non-essential function in the target cell type. The use of fluorescent NSM excludes random integration events, enabling clearer sorting gates and isolated biallelic populations. This constitutes an advancement over similar approaches ([@bib6]). However, potential limitations are that PSMs could be subjected to position-effect variegation or promotor silencing. Nevertheless, usage of the FP markers expedites the selection, reducing the timescale in comparison with potential position-effect variegation ([@bib19]). It should be noted that editing approaches that use single-stranded DNA (ssDNA) or dsDNA could be subjected to cleavage within non-functional or functional sequences. Hence, donor break points within PSM cannot be fully excluded. The advantage of dsDNA approaches, in comparison with ssDNA, are their flexibility to carry larger cargos in order to deposit designer insertions, designer deletions, or PSMs. In addition, larger sequences of donors are easier to detect by conventional methods in comparison with short ssDNA. Similarly, potential imperfect integration of dsDNA donor templates can be readily detected by simple methods such as PCR, in comparison with ssDNA-based methods.

Conventional derivation of single nucleotide mutations, not associated with a direct selection phenotype or selection marker, can require screening an average of 911 ± 375 clones and using 8.8 ± 5.9 sgRNAs. Conversely, early elimination of undesirable outcomes obviates the need to perform extensive colony screening and results in a faster, more efficient derivation process. Thus, FACE constitutes an attractive alternative to conventional methods. The efficiency of homology-directed repair is influenced by the length of the homology arms used ([@bib9]). We and others have used homology arms of ∼1 kbp, which provides a balance between efficiency and specificity ([@bib25]). The sequence conversion from an endogenous sequence to that carried in donor templates extends from ∼400 bp in dsDNA ([@bib7]) to ∼30 bp in ssDNA donors ([@bib20]). Hence, it is of critical importance to include the edited bases close to the dsDNA break point and close to the PSM unit, independently of the length of the homology arms or the type of template used. Post-knockin and post-transposition clonal composition analysis confirmed that FACE enables the derivation of polyclones and significantly reduces the screening efforts if individual clones are needed. On the other hand, the derivation of edited polyclones presents the advantage of avoiding the risk inherent with clone-specific biases. Extensive expansion, required for clonal derivation, is reported to subject cells to culture aberrations ([@bib17]). It is widely accepted that single-cell passaging for any type of cell-culture application, including the process of FACS-based enrichment described here, imposes an unavoidable risk of genome instability ([@bib4]). The derivation of polyclones reduces the culture time needed for each step, since sufficient material is available earlier. Karyotype analysis of the edited lines demonstrated that the process did not induce chromosomal abnormalities when compared with the parental line. Previous reports also support the possibility of achieving a low incidence of modification with genome editing tools ([@bib26], [@bib27]).

In order to protect the dsDNA donor template from Cas9-induced linearization and to avoid post-integration cleavage of targeted sequences, we introduced silent mutations in the PAM sequences. This requires special attention to the design in order to introduce the edited PAM in a non-coding sequence or as a synonymous mutation. We and others have successfully used this mechanistic insight to protect post-integration targeted sequences from secondary cleavage events ([@bib10], [@bib20]). Similarly, design considerations are needed to identify adjacent transposase excision sequences, or to generate a *de novo* TTAA sequence in non-coding regions or by silent editions. Protocol optimization for the use of an excision-only transposase variant ([@bib16]) allowed the derivation of footprint-free isogenic sets for disease modeling. We were able to observe transition states that represent the removal of one or both PSMs. The transition populations presented a curve pattern that accounts for the dissimilar stability of the FPs ([@bib24]) and transcripts after the CDS module was removed.

The influence of repetitive elements on the efficiency of genome editing has been reported previously ([@bib12]). Recognizable repetitive elements constitute up to 45% of the human genome ([@bib14]). Repetitive elements in humans can be classified in four families: SINE, LINE, LTR retrotransposons, and DNA transposons. Each category presents multiple sub-families. Using linear optimization modeling, we determined that, in our dataset, the repetitive elements of the SINE family, Alu and Mir, contribute the most to random integration events. These repetitive elements have 1.5 million copies and constitute ∼13% of the human genome ([@bib14]). Although this discrete dataset does not include all existing human repetitive elements, it demonstrates their direct contribution to random integration. Other aspects, such as the composition of repetitive elements and distance to the dsDNA break point, might modulate the frequency of random integration. Our data confirm previous reports that repetitive elements act as templates for off-target homologous recombination ([@bib12]). These sequences should be avoided when designing homology arms in order to enhance on-target recombination and edition.

In summary, we generated an isogenic set of human *SNCA* mutants for PD-specific cellular modeling. The set carries disease-associated mutations p.A30P or p.A53T in the *SNCA* gene. We observed energy metabolism phenotypes in human NESCs, an early neurodevelopment disease model. Such traits have been previously described in *SNCA* p.A30P mutant differentiated neurons ([@bib23]). This validates the applicability of the approach described here for the generation of disease-relevant models. We envision that FACE could be efficiently implemented for automated high-throughput genome editing, enabling fast phenotype assessment in the future.

Experimental Procedures {#sec4}
=======================

Stem cells A13777 were cultured in Essential 8 medium on Geltrex. Cells were passed with accutase and plated with Y27632 (10 μM) for 24 hr after dissociation. Cells were electroporated using 4D-Nucleofector. Selection was conducted with puromycin (0.5 μg/mL). FACS was conducted on an ARIA III sorter. Cells were purified with single-cell exclusive gating. Post-knockin cells were transfected with *in vitro* transcribed mRNA coding transposase. Human iPSCs were characterized for OCT4, SOX2, TRA1-81, and TRA1-61. Microarray karyotype was conducted using Illumina iScan technology. NESCs were differentiated as represented in [Figure 4](#fig4){ref-type="fig"}A. NESCs were characterized for NESTIN and SOX2. Transcription levels for NESCs were evaluated using Affymetrix human gene arrays (GEO: GSE101534). Extracellular energy flux analysis was conducted on NESCs using a Seahorse XFe96 assay as indicated in [Figure 4](#fig4){ref-type="fig"}D. Comprehensive information on the experimental procedures is described in the [Supplemental Information](#app3){ref-type="sec"}.
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